Expertise in
16
conditions

Alberto A. Zambon

Via Giustiniani 2, 
Padova, IT 
Expertise in
16
conditions
Via Giustiniani 2, 
Padova, IT 

Overview

Alberto Zambon practices practicing medicine in Padova, Italy.

Mr. Zambon is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Leukodystrophy, Metachromatic Leukodystrophy, CACH Syndrome, and Familial Hypertriglyceridemia.

He is actively involved in clinical research, co-authoring 103 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Via Giustiniani 2, Padova, 35128, Italy
Other Locations
Milan, Italy
Bologna, Italy
Via Milanese 300, Sesto San Giovanni, 20099, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III, Single Arm, Open Label, International, Multi Centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid Lowering Therapy
Phase III, Single Arm, Open Label, International, Multi Centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid Lowering Therapy
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drug: Lomitapide
Study Phase: Phase 3
Effects of Fenofibrate on Endothelial Progenitor Cell Levels in Diabetic Patients With Retinopathy. A Randomized Controlled Trial.
Effects of Fenofibrate on Endothelial Progenitor Cell Levels in Diabetic Patients With Retinopathy. A Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: December 19, 2019
Intervention Type: Drug
Study Phase: Phase 4
A Phase Ib, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of Rimeporide in Patients With Duchenne Muscular Dystrophy
A Phase Ib, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of Rimeporide in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: July 18, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

103 Total Publications

Focus on lipoprotein(a).
Focus on lipoprotein(a).
Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: May 08, 2026

Frequently Asked Questions about Alberto A. Zambon

Is Alberto A. Zambon a top-rated expert for Leukodystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Alberto A. Zambon is classified as an Elite expert for Leukodystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alberto A. Zambon participate in research or clinical trials?

Yes. Alberto A. Zambon has published 103 articles and abstracts on conditions like Leukodystrophy. You can view a list of Alberto A. Zambon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zambon's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile